📰 Try Law News
Page 2 - Try Law News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Try Law. Real-time updates on events, politics, business and more.
July 2, 2022
A surprising leak. A big retirement. Blockbuster decisions. Here, Law360 looks at the moments, arguments and opinions that defined the U.S. Supreme Court's latest term.
May 4, 2022
The U.S. Supreme Court is prepared to strike down the landmark 1973 ruling Roe v. Wade that made abortion legal around the country, according to a leaked draft opinion penned by Justice Samuel Alito and published Monday by Politico. Here, Law360 looks at the impact of the court's draft decision and the leak.
March 2, 2022
President Joe Biden nominated D.C. Circuit Judge Ketanji Brown Jackson to replace Justice Stephen Breyer on the U.S. Supreme Court. If confirmed, she would become the first Black female justice to serve on the high court. Here, Law360 looks at Judge Jackson and the confirmation process.
January 27, 2022
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Research Update Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient Safety and Survival from Right to Try Use of Aviptadil During Omicron Surge 27-Jan-2022 / 07:15 CET/CEST Release of an a...
January 27, 2022
RELIEF THERAPEUTICS Holding AG / Key word(s): Research Update27-Jan-2022 / 07:15 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient...
January 27, 2022
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Research Update Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient Safety and Survival from
January 26, 2022
/PRNewswire/ -- NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage, biopharmaceutical company, has received a first safety report from a Southwestern...
January 26, 2022
/PRNewswire/ -- NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage, biopharmaceutical company, has received a first safety report from a Southwestern...
September 29, 2021
A Trump-era program was intended to root out Chinese state-sponsored economic espionage. Instead, critics say, it stirred up a toxic mix of racial profiling and prosecutorial misconduct, leaving innocent scientists to suffer the consequences.
July 22, 2021
As Girardi Scandal Deepens, Lawmakers And Bar Trade Blame By Brandon Lowrey | July 21, 2021, 4:19 PM EDT State legislators are threatening the State Bar of California’s funding for next year, demanding answers as to why it failed for decades to stop famed lawyer Thomas V. Girardi as he allegedly stole from his clients. But the move has prompted the bar to place some of the blame on lawmakers’ unwillingness to increase its funding. This is the third story in our series exami...